1. Home
  2. AVBP vs CLNE Comparison

AVBP vs CLNE Comparison

Compare AVBP & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • CLNE
  • Stock Information
  • Founded
  • AVBP 2021
  • CLNE 2001
  • Country
  • AVBP United States
  • CLNE United States
  • Employees
  • AVBP N/A
  • CLNE N/A
  • Industry
  • AVBP
  • CLNE Natural Gas Distribution
  • Sector
  • AVBP
  • CLNE Utilities
  • Exchange
  • AVBP NYSE
  • CLNE Nasdaq
  • Market Cap
  • AVBP 705.8M
  • CLNE 610.0M
  • IPO Year
  • AVBP 2024
  • CLNE 2007
  • Fundamental
  • Price
  • AVBP $25.22
  • CLNE $1.90
  • Analyst Decision
  • AVBP Strong Buy
  • CLNE Strong Buy
  • Analyst Count
  • AVBP 7
  • CLNE 3
  • Target Price
  • AVBP $39.29
  • CLNE $4.33
  • AVG Volume (30 Days)
  • AVBP 377.5K
  • CLNE 2.8M
  • Earning Date
  • AVBP 08-13-2025
  • CLNE 08-06-2025
  • Dividend Yield
  • AVBP N/A
  • CLNE N/A
  • EPS Growth
  • AVBP N/A
  • CLNE N/A
  • EPS
  • AVBP N/A
  • CLNE N/A
  • Revenue
  • AVBP N/A
  • CLNE $415,920,000.00
  • Revenue This Year
  • AVBP $66.25
  • CLNE $2.47
  • Revenue Next Year
  • AVBP N/A
  • CLNE $9.38
  • P/E Ratio
  • AVBP N/A
  • CLNE N/A
  • Revenue Growth
  • AVBP N/A
  • CLNE 4.85
  • 52 Week Low
  • AVBP $15.47
  • CLNE $1.30
  • 52 Week High
  • AVBP $36.37
  • CLNE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 67.19
  • CLNE 53.04
  • Support Level
  • AVBP $22.65
  • CLNE $1.76
  • Resistance Level
  • AVBP $25.80
  • CLNE $2.05
  • Average True Range (ATR)
  • AVBP 1.32
  • CLNE 0.12
  • MACD
  • AVBP 0.18
  • CLNE 0.00
  • Stochastic Oscillator
  • AVBP 87.89
  • CLNE 58.33

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: